Dr. Edwin Medilabs Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.39 M
- Revenue Growth 2.22%
- Profit Growth 0.94%
- Ebitda 0.74%
- Net Worth 42.22%
- Total Assets 3.02%
About Dr. Edwin Medilabs
Dr. Edwin Medilabs Private Limited (DEMPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 December 2019 (Five years and one month 26 days old ). Its registered office is in Rupnagar, Punjab, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹7.39 M.
Ved Prakash, Vinod Dhawan, Shailendra, and One other member serve as directors at the Company.
Company Details
- Location
Rupnagar, Punjab, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24100PB2019PTC050368
- Company No.
050368
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Dec 2019
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Dr. Edwin Medilabs?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ved Prakash  | Director | 05-Dec-2019 | Current |
| Vinod Dhawan | Director | 05-Dec-2019 | Current |
| Shailendra | Director | 11-Aug-2022 | Current |
| Sher Mehra | Director | 11-Aug-2022 | Current |
Financial Performance of Dr. Edwin Medilabs.
Dr. Edwin Medilabs Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.22% increase. The company also saw a slight improvement in profitability, with a 0.94% increase in profit. The company's net worth Soared by an impressive increase of 42.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr. Edwin Medilabs?
Unlock access to Dr. Edwin Medilabs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹7.39 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.74 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Apr 2024 | Others | ₹7.39 M | Open |
How Many Employees Work at Dr. Edwin Medilabs?
Dr. Edwin Medilabs has a workforce of 32 employees as of Sep 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr. Edwin Medilabs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. Edwin Medilabs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
